Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.

Van Cutsem, E

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jan 2015 - 149-156 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1569-8041

10.1093/annonc/mdu496 doi


Adenocarcinoma--drug therapy
Antineoplastic Agents--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Capecitabine
Deoxycytidine--adverse effects
Disease-Free Survival
Docetaxel
Drug Administration Schedule
Female
Fluorouracil--adverse effects
Humans
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Organoplatinum Compounds--adverse effects
Oxaliplatin
Prospective Studies
Stomach Neoplasms--drug therapy
Taxoids--adverse effects
Treatment Outcome